NCT01989546 2021-02-23Pilot Trial of BMN 673, an Oral PARP Inhibitor, in Patients With Advanced Solid Tumors and Deleterious BRCA MutationsNational Institutes of Health Clinical Center (CC)Phase 1/2 Completed9 enrolled 11 charts